Current drug safety
Fatigue Associated with Trastuzumab Deruxtecan in Solid Tumors: A Meta-Analysis and Pharmacovigilance Signal Detection Study.
Yinyin Ye, Yuyao Tang, Yongxin Li, Chengrong Zhang, Xinlong Tao, Qianyue Ma, Jiuda Zhao
Published: 202610.2174/0115748863400146251007114813
Abstract
INTRODUCTION: With the increasing use of trastuzumab deruxtecan (T-DXd) in the treatment of solid tumors, fatigue has emerged as a clinically significant toxicity. We aimed to quantify the risk and incidence of T-DXd-associated fatigue using randomiz…
Preview only. Read the full abstract at the source